AZN vs NKTX · P/E 28, $288.38B cap vs $188.9M cap
AstraZeneca PLC (AZN) versus Nkarta Inc (NKTX) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Nkarta Inc (NKTX) is a biotechnology company listed on NASDAQ.
AZN does not have a complete income-statement cache yet.
Latest reported NKTX revenue for 2025-12-31 was $0. Net income was -$104.1M. NKTX currently screens at market cap $188.9M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. NKTX currently screens at market cap $188.9M.
Not investment advice. Open the AZN and NKTX stock pages for the full models.
Not investment advice.